ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,91
-1,31%
Dow Jones
41 433,48
-1,14%
DAX
22 328,77
-1,23%
Brent Oil
69,705
-0,01%
Bitcoin
83 020,13
0,21%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. SpringWorks Therapeutics Inc (SWTX) Cours

SpringWorks Therapeutics Inc

SpringWorks Therapeutics Inc (SWTX)

NASDAQ
50,89
2,45
(5,06%)
Fermé 12 Mars 9:00PM
Retardé de 15 minutes
50,95
0,06
(0,12%)
Après les heures de négociation: 12:25AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
50,95
Prix Achat
50,87
Prix Vente
51,00
Volume échangé
2 278 537
47,41 Fourchette du Jour 51,67
28,21 Plage de 52 semaines 62,00
Cap du marché
3,818B
Clôture Veille
48,44
Ouverture
48,50
Dernière Transaction
10
@
51
Dernière heure de transaction
Volume financier
US$ 112 566 165
VWAP
49,4028
Volume moyen (3 m)
2 363 424
Actions en circulation
74 935 850
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,76
Bénéfice par action (BPA)
-3,44
Chiffre d'affairess
191,59M
Bénéfice net
-258,13M

À propos de SpringWorks Therapeutics Inc

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differenti... SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.springworkstx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
SpringWorks Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker SWTX. Le dernier cours de clôture d'SpringWorks Therapeutics était de US$48,44. Au cours de la dernière année, les actions de SpringWorks Therapeutics ont été négociées dans une fourchette de prix de US$ 28,21 à US$ 62,00.

SpringWorks Therapeutics compte actuellement 74 935 850 actions en circulation. La capitalisation boursière d'SpringWorks Therapeutics est de US$3,63 milliard. SpringWorks Therapeutics a un ratio cours/bénéfice (ratio PE) de -14.76.

Flux d'options SpringWorks Therapeutics (SWTX)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

8M

Calls / Puts

193,27%

Ach. / Vent.

110,22%

OTM / ITM

64,86%

Sweeps Ratio

0,00%

SWTX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
SWTX (5,06%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 Février 2025
SWTX (5,06%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
20 Février 2025
SWTX (5,06%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
20 Février 2025
SWTX (5,06%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
20 Février 2025
SWTX (5,06%)

Form 8-K - Current report
Edgar (US Regulatory)
20 Février 2025
SWTX (5,06%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 Février 2025
SWTX (5,06%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.35-4.4090056285253.353.59546.63290347350.38402799CS
4-2.8-5.2093023255853.756246.63325023455.18901351CS
1213.1734.859714134537.786231.955236342448.18505246CS
2612.4132.200311364838.546228.21167554043.17350104CS
52-0.1-0.19588638589651.056228.21124807142.55259657CS
156-9.68-15.96569355160.6365.9213.6100212235.54974942CS
26018.3856.432299662332.5796.4813.671357940.07925669CS

SWTX - Frequently Asked Questions (FAQ)

What is the current SpringWorks Therapeutics share price?
The current share price of SpringWorks Therapeutics is US$ 50,95
How many SpringWorks Therapeutics shares are in issue?
SpringWorks Therapeutics has 74 935 850 shares in issue
What is the market cap of SpringWorks Therapeutics?
The market capitalisation of SpringWorks Therapeutics is USD 3,63B
What is the 1 year trading range for SpringWorks Therapeutics share price?
SpringWorks Therapeutics has traded in the range of US$ 28,21 to US$ 62,00 during the past year
What is the PE ratio of SpringWorks Therapeutics?
The price to earnings ratio of SpringWorks Therapeutics is -14,76
What is the cash to sales ratio of SpringWorks Therapeutics?
The cash to sales ratio of SpringWorks Therapeutics is 19,89
What is the reporting currency for SpringWorks Therapeutics?
SpringWorks Therapeutics reports financial results in USD
What is the latest annual turnover for SpringWorks Therapeutics?
The latest annual turnover of SpringWorks Therapeutics is USD 191,59M
What is the latest annual profit for SpringWorks Therapeutics?
The latest annual profit of SpringWorks Therapeutics is USD -258,13M
What is the registered address of SpringWorks Therapeutics?
The registered address for SpringWorks Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the SpringWorks Therapeutics website address?
The website address for SpringWorks Therapeutics is www.springworkstx.com
Which industry sector does SpringWorks Therapeutics operate in?
SpringWorks Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RAYRaytech Holding Ltd
US$ 1,69
(94,25%)
104,03M
TSVT2seventy bio Inc
US$ 4,945
(76,61%)
30,77M
HSAIHesai Group
US$ 24,10
(50,53%)
26,08M
SPHLSpringview Holdings Ltd
US$ 6,00
(47,06%)
1,62M
SYRSSyros Pharmaceuticals Inc
US$ 0,1334
(45,63%)
688,81M
WCTWellchange Holdings Company Limited
US$ 0,68417
(-72,74%)
37,72M
ARVNArvinas Inc
US$ 8,29
(-52,79%)
19,03M
LZMHLZ Technology Holdings Ltd
US$ 8,011
(-48,84%)
685,95k
HTCOHigh Trend International Group
US$ 1,41
(-33,80%)
188,46k
SPGCSacks Parente Golf Inc
US$ 0,1061
(-33,73%)
36,38M
SYRSSyros Pharmaceuticals Inc
US$ 0,1334
(45,63%)
695,66M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0402
(20,00%)
411,84M
NVDANVIDIA Corporation
US$ 108,76
(1,66%)
354,43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,93
(7,45%)
304,67M
CUTRCutera Inc
US$ 0,1079
(-16,03%)
218,46M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SWTX
SpringWorks Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces